Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.

Emiel LeegwaterLisa DolMenno R BenardEveline E RoelofsenNathalie M DelfosMachteld van der FeltzFemke P N MollemaLiesbeth B E BosmaLoes E VisserThomas H OttensNathalie D van BurgelSesmu M ArbousLahssan H El BouazzaouiRachel KnevelRolf H H GroenwoldMark G J de BoerLeo G VisserFrits R RosendaalErik B WilmsCees van Nieuwkoop

Published in: Infectious diseases and therapy (2023)

Remdesivir generally does not increase the incidence of rapid clinical improvement in hospitalised patients with COVID-19, but it might have an effect in patients with short duration of symptoms and limited signs of systemic inflammation.

Keyphrases

loop mediated isothermal amplification
sars cov
community acquired pneumonia
magnetic resonance
clinical trial
risk factors
cross sectional
network analysis
double blind
magnetic resonance imaging
depressive symptoms